251 related articles for article (PubMed ID: 30011032)
1. Competing Risks in Older Patients With Cancer: A Systematic Review of Geriatric Oncology Trials.
Burdett N; Vincent AD; O'Callaghan M; Kichenadasse G
J Natl Cancer Inst; 2018 Aug; 110(8):825-830. PubMed ID: 30011032
[TBL] [Abstract][Full Text] [Related]
2. Designing therapeutic clinical trials for older and frail adults with cancer: U13 conference recommendations.
Hurria A; Dale W; Mooney M; Rowland JH; Ballman KV; Cohen HJ; Muss HB; Schilsky RL; Ferrell B; Extermann M; Schmader KE; Mohile SG;
J Clin Oncol; 2014 Aug; 32(24):2587-94. PubMed ID: 25071116
[TBL] [Abstract][Full Text] [Related]
3. Changes in the Use of Comprehensive Geriatric Assessment in Clinical Trials for Older Patients with Cancer over Time.
Le Saux O; Falandry C; Gan HK; You B; Freyer G; Péron J
Oncologist; 2019 Aug; 24(8):1089-1094. PubMed ID: 30710065
[TBL] [Abstract][Full Text] [Related]
4. End points and trial design in geriatric oncology research: a joint European organisation for research and treatment of cancer--Alliance for Clinical Trials in Oncology--International Society Of Geriatric Oncology position article.
Wildiers H; Mauer M; Pallis A; Hurria A; Mohile SG; Luciani A; Curigliano G; Extermann M; Lichtman SM; Ballman K; Cohen HJ; Muss H; Wedding U
J Clin Oncol; 2013 Oct; 31(29):3711-8. PubMed ID: 24019549
[TBL] [Abstract][Full Text] [Related]
5. Geriatric assessment in daily oncology practice for nurses and allied health care professionals: Opinion paper of the Nursing and Allied Health Interest Group of the International Society of Geriatric Oncology (SIOG).
Burhenn PS; McCarthy AL; Begue A; Nightingale G; Cheng K; Kenis C
J Geriatr Oncol; 2016 Sep; 7(5):315-24. PubMed ID: 26961585
[TBL] [Abstract][Full Text] [Related]
6. Evaluation of the quality of the reporting of phase II clinical trials in oncology: A systematic review.
Rivoirard R; Langrand-Escure J; Oriol M; Tinquaut F; Chauvin F; Rancoule C; Magné N; Bourmaud A
Crit Rev Oncol Hematol; 2018 May; 125():78-83. PubMed ID: 29650280
[TBL] [Abstract][Full Text] [Related]
7. Analysis of the yield of phase II combination therapy trials in medical oncology.
Maitland ML; Hudoba C; Snider KL; Ratain MJ
Clin Cancer Res; 2010 Nov; 16(21):5296-302. PubMed ID: 20837695
[TBL] [Abstract][Full Text] [Related]
8. Addressing the quality of life needs of older patients with cancer: a SIOG consensus paper and practical guide.
Scotté F; Bossi P; Carola E; Cudennec T; Dielenseger P; Gomes F; Knox S; Strasser F
Ann Oncol; 2018 Aug; 29(8):1718-1726. PubMed ID: 30010772
[TBL] [Abstract][Full Text] [Related]
9. Practical Assessment and Management of Vulnerabilities in Older Patients Receiving Chemotherapy: ASCO Guideline for Geriatric Oncology.
Mohile SG; Dale W; Somerfield MR; Schonberg MA; Boyd CM; Burhenn PS; Canin B; Cohen HJ; Holmes HM; Hopkins JO; Janelsins MC; Khorana AA; Klepin HD; Lichtman SM; Mustian KM; Tew WP; Hurria A
J Clin Oncol; 2018 Aug; 36(22):2326-2347. PubMed ID: 29782209
[TBL] [Abstract][Full Text] [Related]
10. Comprehensive Geriatric Assessment in the Older Adult with Cancer: A Review.
Hernandez Torres C; Hsu T
Eur Urol Focus; 2017 Oct; 3(4-5):330-339. PubMed ID: 29331624
[TBL] [Abstract][Full Text] [Related]
11. Engineering the fitness of older patients for chemotherapy: an exploration of Comprehensive Geriatric Assessment in practice.
McCarthy AL; Cook PS; Yates P
Health (London); 2014 Mar; 18(2):196-212. PubMed ID: 23703221
[TBL] [Abstract][Full Text] [Related]
12. Diffuse large B-cell lymphoma in the elderly: impact of prognosis, comorbidities, geriatric assessment, and supportive care on clinical practice. An International Society of Geriatric Oncology (SIOG) expert position paper.
Morrison VA; Hamlin P; Soubeyran P; Stauder R; Wadhwa P; Aapro M; Lichtman S
J Geriatr Oncol; 2015 Mar; 6(2):141-52. PubMed ID: 25491101
[TBL] [Abstract][Full Text] [Related]
13. Phase III trials in oncology: setting standards of care?
Seeber S; Braun AH
Nat Clin Pract Oncol; 2005 Sep; 2(9):426-7. PubMed ID: 16264993
[No Abstract] [Full Text] [Related]
14. Addressing heterogeneity in the design of phase II clinical trials in geriatric oncology.
Cabarrou B; Sfumato P; Mourey L; Leconte E; Balardy L; Martinez A; Delord JP; Boher JM; Brain E; Filleron T
Eur J Cancer; 2018 Nov; 103():120-126. PubMed ID: 30223225
[TBL] [Abstract][Full Text] [Related]
15. Beyond the black box of geriatric assessment: Understanding enhancements to care by the geriatric oncology clinic.
Alibhai SMH; Jin R; Loucks A; Yokom DW; Watt S; Puts M; Timilshina N; Berger A
J Geriatr Oncol; 2018 Nov; 9(6):679-682. PubMed ID: 29631899
[TBL] [Abstract][Full Text] [Related]
16. A multidisciplinary approach is required to increase the quality of phase II/III clinical studies on biotherapies in oncology.
Ottaiano A; Budillon A; Normanno N; Iaffaioli VR; Caraglia M
Ann Oncol; 2007 May; 18(5):960-1. PubMed ID: 17437968
[No Abstract] [Full Text] [Related]
17. How and why to perform a geriatric assessment in clinical practice.
Terret C
Ann Oncol; 2008 Sep; 19 Suppl 7():vii300-3. PubMed ID: 18790970
[No Abstract] [Full Text] [Related]
18. Incorporation of geriatric principles in oncology clinical trials.
Hurria A
J Clin Oncol; 2007 Dec; 25(34):5350-1. PubMed ID: 18048814
[No Abstract] [Full Text] [Related]
19. Role of Geriatric Oncologists in Optimizing Care of Urological Oncology Patients.
Droz JP; Boyle H; Albrand G; Mottet N; Puts M
Eur Urol Focus; 2017 Oct; 3(4-5):385-394. PubMed ID: 29128297
[TBL] [Abstract][Full Text] [Related]
20. A literature review of applied adaptive design methodology within the field of oncology in randomised controlled trials and a proposed extension to the CONSORT guidelines.
Mistry P; Dunn JA; Marshall A
BMC Med Res Methodol; 2017 Jul; 17(1):108. PubMed ID: 28720094
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
